HUM-MOLGEN events: Discovery on Target

Masanori Aikawa, Ph.D., Yoshihiro Miwa Assoc Chair & Dir, Ctr for Interdisciplinary Cardiovascular Sciences, Brigham & Womens Hospital
Bernard Allan, Ph.D., Sr Scientist, Molecular Biology, Genentech Inc
Andrew Alt, Ph.D., Sr Research Investigator II, Lead Discovery, Bristol Myers Squibb Co
Stephen Antonysamy, Ph.D., Principal Research Scientist, Structural Biology, Eli Lilly & Co
Cheryl Arrowsmith, Ph.D., Principal Investigator, Medical Biophysics, Univ of Toronto
Irfan Asangani, Ph.D., Research Investigator Pathology, Michigan Ctr for Translational Pathology, Univ of Michigan
Geoffrey Bartholomeusz, Asst Prof, Experimental Therapeutics, MD Anderson Cancer Ctr
Louise Baskin, Sr Product Manager, Dharmacon Products, Thermo Fisher Scientific Inc
Eralp Al Bellibas, M.D., Sr Dir & Head, Clinical Pharmacology, Medicines Co
Alexander Bishop, Asst Prof Cellular & Structural Biology, Greehey Childrens Cancer Research Institute, Univ of Texas San Antonio
James Bradner, Asst Prof, Hematologic Oncology, Dana Farber Cancer Institute
David Bramhill, Founder, Bramhill Biological Consulting LLC, Individual Consultant
Abraham Brass, Asst Prof, Microbiology & Physiological Systems, Univ Of Massachusetts
David Budd, Ph.D., Honorary Lecturer Inflammation, Ctr for Rheumatology & Connective Tissue Diseases, Univ College London
Eugen Buehler, Team Leader, Informatics, NIH NHGRI
Mark Bures, Ph.D., Research Advisor, Chemistry, Eli Lilly & Co
Neil Burford, Ph.D., Sr Research Investigator II, Lead Discovery, Bristol Myers Squibb Co
Kyle Butler, Ph.D., Graduate Research Asst, Medicinal Chemistry & Pharmacognosy, Univ Of Illinois Chicago
Robert Carithers, Prof of Medicine, Gastroenterology, Univ of Washington
Gregory Carven, Assoc Research Fellow & Head, Global Biotherapeutics Technologies, Pfizer Research Labs
Robert Casero Jr, Ph.D., Prof, Oncology Cancer Biology, Johns Hopkins Univ
Sylvain Celanire, Ph.D., Assoc Research Dir Medicinal Chemistry, Medicinal Chemistry, Addex Therapeutics
DeKuan Chang, Research Fellow, Cancer Immunology & AIDS, Dana Farber Cancer Institute
Zhongyi Cheng, PTM Biolabs Inc
Xiaodong Cheng, Ph.D., Professor & Georgia Eminent Scholar, Biochemistry, Emory Univ
Partha Chowdhury, Principal Scientist, Antibody Discovery & Protein Engineering, MedImmune
Ruiyin Rick Chu, Principal Investigator, Functional Genomics, Genzyme Corp A Sanofi Co
Namjin Chung, Sr Research Investigator, Applied Genomics, Bristol Myers Squibb Co
John Corbin, Assoc Dir Molecular Interactions & Biophysics, Preclinical Research, XOMA US LLC
Alan Corin, Ph.D., Dir Biochemistry & Molecular Pharmacology, Biochemistry & Molecular Pharmacology, Celgene
Charles Craik, Prof, Pharmaceutical Chemistry, Univ of California San Francisco
Danette Daniels, Ph.D., Grp Leader, R&D Functional Proteomics, Promega Corp
Hans De Haard, Ph.D., CSO, Research, arGEN X BVBA
Ario De Marco, Ph.D., Dir Biotechnological Platform, Therapeutic Antibody Platform, Institut Curie
Gerald Denis, Ph.D., Asst Prof, Cancer Ctr, Boston Univ
John Denu, Ph.D., Prof, Biomolecular Chemistry, Univ of Wisconsin Madison
Paul Diehl, Dir Marketing & Bus Dev, Marketing & Bus Dev, Cellecta Inc
Rajan Dighe, Ph.D., Prof, Molecular Reproduction & Dev & Genetics, Indian Institute of Science
Marcel Dinger, Ph.D., Assoc Prof & Head Clinical Genomics, Clinical Genomics Ctr, Garvan Institute of Medical Research
Hakim Djaballah, Dir HTS Core Facility, Molecular Pharmacology & Chemistry Program, Memorial Sloan Kettering Cancer Ctr
John Doench, Scientist, RNAI Platform, Broad Institute
Dario Doller, Ph.D., Dir Discovery Chemistry & DMPK, Discovery Chemistry & DMPK, Lundbeck Research USA
Yali Dou, Ph.D., Assoc Prof, Pathology, Univ of Michigan
John Douhan, Ph.D., Principal Scientist, Inflammation, Pfizer Research Labs
Frederic Ducancel, Head, Institute of Biology and Technology, CEA Saclay
Donald Durden, M.D., Ph.D., CEO, SignalRx Pharmaceuticals Inc
Hilmar Ebersbach, Lab Head, Antibody Generation, Novartis Pharma AG
Christophe Echeverri, CEO & CSO, Cenix BioScience USA Inc
Pascal Egloff, Scientist, Biochemistry Institute, Univ Of Zurich
Daniel Erlanson, Ph.D., Co Founder & President, Chemistry, Carmot Therapeutics Inc
Marco Falasca, Ph.D., Prof, Molecular Pharmacology & Diabetes, Queen Mary Univ of London
John Feder, Assoc Dir Genome Biology, Genome Biology, Bristol Myers Squibb Co
Paul Feldman, Ph.D., VP Medicinal Chemistry, Medicinal Chemistry, GlaxoSmithKline
Maria Francipane, Ph.D., Postdoc Research Scholar, Pathology, Univ of Pittsburgh
Christopher French, M.D., Asst Prof, Pathology, Brigham & Womens Hospital
Jordan Fridman, Ph.D., Exec Dir, Incyte Corp
Matthew Fuchter, Ph.D., Sr Lecturer, Synthetic & Medicinal Chemistry, Imperial College London
George Gaitanaris, M.D., Ph.D., VP Science, Science, Omeros Corp
Alex Gaither, Lab Head, Developmental & Molecular Pathways, Novartis Institutes for BioMedical Research Inc
Matthew Gardener, Ph.D., Sr Scientist, ADPE, MedImmune Ltd
Gilles Gnacadja, Ph.D., Principal Analyst, System Informatics, Amgen Inc
Val Goodfellow, Ph.D., CEO, Califia Bio Inc
Daniel Grau, Ph.D., , Heptares Therapeutics Ltd
David Grayzel, Managing Dir, Atlas Venture
Leonard Guarente, Prof, Biology, Massachusetts Institute of Technology
Lorraine Gudas, Ph.D., Chairman, Pharmacology, Cornell Univ
Wayne Hancock, Prof & Chief, Pathology & Transplantation Immunology, Childrens Hospital of Philadelphia
Michael Hanson, Ph.D., Dir Structural Biology, Structural Biology, Receptos Inc
William Harriman, CSO & Founder, Crystal Bioscience
Joseph Hill, Prof, Internal Medicine & Molecular Biology, Univ of Texas Dallas
Gregory Hoffman, , Systems Biology, Harvard Medical School
Edward Holson, Dir Medicinal Chemistry, Medicinal Chemistry, Broad Institute
Corey Hopkins, Ph.D., Asst Prof, Neuroscience Drug Discovery Ctr, Vanderbilt Univ
Catherine Hutchings, Ph.D., Antibody Project Manager, Antibody Discovery & Strategic Partnering, Heptares Therapeutics Ltd
Lindsey Ingerman James, Ph.D., Research Asst Prof, Ctr for Integrative Chemical Biology & Drug Dis, Univ of North Carolina Chapel Hill
Anass Jawhari, Ph.D., CSO, Membrane Protein Alliance
Xuliang Jiang, Ph.D., Assoc Dir Structural Biology & Computational Chem, Structural Biology & Computational Chemistry, EMD Serono Research & Development Institute Inc
Jan Johansson, M.D., Ph.D., CEO & President, Corp, Artery Therapeutics Inc
Paul Kassner, Dir Research, Research, Amgen Inc
Vsevolod Katritch, Ph.D., Asst Prof, Molecular Biology, Scripps Research Institute
Debra Kendall, Ph.D., Prof, Pharmaceutical Sciences, Univ Of Connecticut Storrs
Eldar Kim, CSO, MSM Protein Technologies Inc
Chadwick King, Principal Scientist, Biologics Discovery, Amgen Inc
Sarah Knutson, Ph.D., Senior Scientist, Biological Sciences, EpiZyme Inc
Friedrich Koch-Nolte, Prof, Molecular Immunology, Univ Medical Ctr Hamburg Eppendorf
Suneil Koliwad, M.D., Ph.D., Asst Prof, Diabetes Ctr, Univ of California San Francisco
Christopher Koth, Sr Scientist, Structural Biology, Genentech Inc
Ryan Kruger, Ph.D., Manager, Cancer Epigenetics Discovery Performance Unit, GlaxoSmithKline
Tatiana Kutateladze, Ph.D., Assoc Prof, Pharmacology, Univ of Colorado Denver
Susan Lacy, Assoc Dir Global Biologics, Global Biologics, AbbVie Bioresearch Ctr
Kyung Lee, Ph.D., Sr Investigator & Section Head, Lab of Metabolism, NIH NCI
Sophie Lelievre, Assoc Prof, Basic Medical Sciences & Cancer Ctr, Purdue Univ
Min Li, Prof, Neuroscience, Johns Hopkins Univ
Hong Liang, Ph.D., Associate Research Fellow, Rinat Pfizer
Changlu Liu, Ph.D., Principal Scientist, Neurosciences, Johnson & Johnson Pharmaceutical R&D
Xiangdong Liu, Ph.D., Grp Head, Drug Discovery & Dev, Incyte Corp
Mercedes Lobera, Assoc Dir, Tempero Pharmaceuticals Inc
Silvia Locatelli-Hoops, Scientist, Membrane Biochemistry and Biophysics, NIH NIAAA
Brian Lohse, Ph.D., Assoc Prof, Drug Design & Pharmacology, Univ Of Copenhagen
Udo Maier, Ph.D., Head, Target Discovery Research, Boehringer Ingelheim Pharma GmbH & CO KG
Scott Martin, Team Leader RNAi Screening, Chemical Genomics Ctr, NIH NCATS
Lesley Mathews, Contractor, Pre Clinical Innovation, NIH NCATS
Ralph Mazitschek, Asst Prof, Ctr for Systems Biology, Massachusetts General Hospital
Michael McCabe, Ph.D., Investigator, Biology, GlaxoSmithKline
Timothy McKinsey, Assoc Prof & Assoc Head Translational Research, Cardiology Medicine, Univ of Colorado Denver
Gregory Michaud, Sr Investigator I, Developmental & Molecular Pathways, Novartis Institutes for BioMedical Research Inc
Alea Mills, Ph.D., Prof, Functional Genomics, Cold Spring Harbor Lab
Pamela Munster, Prof in Residence, Hematology & Oncology, Univ of California San Francisco
Andrew Niles, Sr Research Scientist, Promega Corp
Scott Noggle, Dir Lab, Lab, New York Stem Cell Foundation
Udo Oppermann, Ph.D., Structural Genomics Consortium, Univ of Oxford
Michael Orsini, Ph.D., Principal Scientist, Metabolic Diseases, Bristol Myers Squibb Co
Dafydd Owen, Ph.D., Assoc Research Fellow, Pfizer Worldwide Medicinal Chemistry, Pfizer Global R&D
Harish Pant, Ph.D., Lab Chief, Neuronal Cytoskeletal Protein Regln, NIH NINDS
Kristen Picha, Dir Centyrex, Biology, Janssen US
William Pitts, Ph.D., Grp Leader, Medicinal Chemistry, Bristol Myers Squibb Co
Kornelia Polyak, M.D., Ph.D., Assoc Prof, Medical Oncology, Dana Farber Cancer Institute
Prem Premsrirut, President & CEO, Mirimus Inc
Pier Lorenzo Puri, Assoc Prof, Childrens Health Research Ctr, Sanford Burnham Medical Research Institute
Kamal Puri, Ph.D., Assoc Dir Research, Research, Gilead Sciences Inc
Elizabeth Quinn, Dir Marketing, LeadHunter Discovery Svcs, DiscoveRx Corp
Palaniswami Rathanaswami, Sr Scientist, Amgen Inc
Peter Ravn, Ph.D., Sr Research Scientist, MedImmune Ltd
Aaron Ring, Graduate Student, Structural Biology, Stanford Univ
John Robinson, Ph.D., Sr Scientist, Medicinal Chem, Array BioPharma Inc
David Root, Dir RNAi Platform, RNAi Platform, Broad Institute
Mette Rosenkilde, Ph.D., Prof, Pharmacology & Neuroscience, Univ of Copenhagen
Heiko Runz, Principal Investigator & Specialist Medical Gen, Molecular Medicine Partnership, Univ of Heidelberg
Thomas Sakmar, Ph.D., Richard M & Isabel P Furlaud Prof, Chemical Biology & Signal Transduction, Rockefeller Univ
Yoshitaka Satoh, Ph.D., Sr Principal Scientist, Medicinal Chemistry, Celgene Corp
Stephan Schann, Ph.D., Head, Research, Domain Therapeutics
Matthieu Schapira, Ph.D., Prof, Structural Genomics Consortium, Univ of Toronto
Jerome Schentag, PharmD, Prof, Pharmaceutical Sciences, SUNY Buffalo
Stuart Schreiber, Ph.D., Dir, Chemical Biology Program, Broad Institute
Eric Schwartz, Ph.D., Sr Dir Chemistry, Chemistry, Celgene
Margrit Schwarz, Ph.D., MS Consulting LLC, Email Address Only
Fiona Scott, Ph.D., Assoc Dir, Biology, Receptos Inc
Jeffrey Settleman, Ph.D., Sr Dir Discovery Oncology, Discovery Oncology, Genentech Inc
Shawn L. Shafer, Ph.D., Market Segment Manager, Functional Genomics, Sigma® Life Science
Caroline Shamu, Lecturer, Systems Biology, Harvard Medical School
David Sheppard, Ph.D., Dir Computational Chemistry, Computational Chemistry, BioFocus
David Sherris, Ph.D., President & CEO, Paloma Pharmaceuticals Inc
Arun Shukla, Asst Prof, Medicine, Duke Univ
Gerald Shulman, Prof, Cellular & Molecular Physiology, Yale Univ
Robert Sims, Ph.D., Dir Biology, Biology, Constellation Pharmaceuticals
Jennifer Smith, Asst Dir, ICCB Longwood Screening Facility, Harvard Medical School
Bryan Smith, Ph.D., Sr Scientist II, Biology, Deciphera Pharmaceuticals
Arjan Snijder, Assoc Prin Scientist, Discovery Sciences, AstraZeneca R&D Molndal
Yongcheng Song, Ph.D., Research Scientist Fellow, Chemistry, Univ Of Illinois Urbana
Jun Sonoda, Ph.D., Scientist, Molecular Biology, Genentech Inc
Ajit Srivastava, Ph.D., Consultant, Integrated Pharma Solutions LLC, Individual Consultant
Peter Staller, Ph.D., Dir Oncology Research, Oncology Research, EpiTherapeutics ApS
Kimberly Stegmaier, M.D., Asst Prof, Pediatrics, Dana Farber Cancer Institute
Jan Steyaert, Ph.D., Head, Structural Biology Brussels Research Ctr, Vrije Univ Brussels
William Strohl, Ph.D., VP Biologics Research, Biologics Research, Janssen Pharmaceuticals Inc
Hosahalli Subramanya, Ph.D., VP Lead Generation, Structural Biology, Aurigene Discovery Technologies Ltd
Roger Sunahara, Ph.D., Asst Prof, Pharmacology, Univ of Michigan
Ronald Swanson, Sr Dir Biologics Research, Biologics Research, Janssen R&D LLC
Alan Tackett, Ph.D., Dir UAMS Proteomics Facility & Assoc Prof, Biochemistry & Molecular Biology, Univ of Arkansas for Medical Sciences
Christopher Tate, Ph.D., Grp Leader, MRC Lab Of Molecular Biology
Rebecca Taub, M.D., Ph.D., CEO, Madrigal Pharmaceuticals
Sean Taverna, Ph.D., Asst Prof, Pharmacology & Molecular Sciences, Johns Hopkins Univ
Donato Tedesco, Sr Research Scientist, Cellecta Inc
Douglas Thomas, Ph.D., Assoc Prof, Medicinal Chemistry, Univ Of Illinois Chicago
Helmut Thomas, Ph.D., Sr VP Research & Preclinical Dev, Research & Preclinical Dev, Tranzyme Pharma Inc
Richard Trauger, CSO, CytoDyn Inc
Raymond Trievel, Ph.D., Assoc Prof, Biological Chemistry, Univ of Michigan
Patrick Trojer, Ph.D., Dir & Head Biology, Biology, Constellation Pharmaceuticals
John Trzupek, Ph.D., Principal Scientist, Pfizer Global R&D
Matt Tudor, Principal Scientist, Screening & Protein Sciences, Merck & Co
Peter Tummino, Ph.D., Sr Dir Biology, Biology, GlaxoSmithKline
Alexandros Tzatsos, M.D., Ph.D., Molecular Oncology Research Institute, Tufts Univ
David Unett, Ph.D., Sr Dir Receptor Pharmacology & Screening, Receptor Pharmacology & Screening, Arena Pharmaceuticals
Stefanie Urlinger, Ph.D., Dir R&D, Discovery Alliances & Technologies, MorphoSys AG
Jonathan Violin, Ph.D., Head, Biology, Trevena Inc
Bridget Wagner, Dir Pancreatic Cell Biology, Chemical Biology Program, Broad Institute
Gangli Wang, Ph.D., Chemistry, Univ Of North Carolina Chapel Hill
Shaomeng Wang, Ph.D., Prof, Internal Medicine & Pharmacology, Univ of Michigan
John Watson, Ph.D., Sr Research Investigator, Lead Discovery, Bristol Myers Squibb Co
Dale Wright, Ph.D., Research Investigator, Pharmacology, Array BioPharma Inc
Hong Xin, Ph. D., Sr Scientist, Lead Generation, Johnson & Johnson Pharmaceutical R&D
Qin Yan, Ph.D., Asst Prof, Pathology, Yale Univ
Tso-Pang Yao, Prof, Pharmacology & Cancer Biology, Duke Univ
Erick Young, Ph.D., Distinguished Research Fellow, Medicinal Chemistry, Boehringer Ingelheim Pharma
Edward Zartler, Ph.D., President and CSO, Quantum Tessera Consulting LLC
Mei Zhang, Sr Scientist, LDT, EMD Serono Research & Development Institute Inc
Yingming Zhao, Prof, Cancer Research, Univ of Chicago
Ting Zhao, , Cardiovascular Surgery, Boston Univ
Qiang Zhou, Scientist, Neuroscience, Genentech Inc
Ming-Ming Zhou, Ph.D., Prof & Chair, Structual & Chemical Biology, Icahn School of Medicine at Mount Sinai
Zhaohui Sunny Zhou, Ph.D., Assoc Prof, Barnett Institute, Northeastern Univ